Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 03, 2007. The report details a specific corporate action regarding the repurchase and cancellation of the company's ordinary shares, executed under authority granted by shareholders at the Annual General Meeting on May 23, 2007.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share buyback transaction:
- Shares Purchased: 3,000,000 ordinary shares of 25 pence each.
- Purchase Price: 1,293.0841 pence per share.
- Transaction Date: December 03, 2007.
Material Changes
Following the cancellation of the repurchased shares, the company's capital structure has changed as follows:
- Treasury Shares: The company now holds 504,194,158 shares in Treasury, representing 9.14% of total voting rights.
- Shares in Issue: There are 5,518,245,946 shares in issue (excluding Treasury shares), which represents the total voting rights in the company.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the updated total voting rights denominator (5,518,245,946 shares) for compliance with Disclosure Transparency Rules.
- Confirm the Treasury share count (504,194,158) and its percentage of total voting rights (9.14%).
- Note that this filing is a notification of a specific share cancellation event and does not contain periodic financial performance data.